ChoA Pharmaceutical Co.Ltd
ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea. The company produces approximately 200 medicines and health foods, including 30 internal ampoule products, such as Hepos, Fematin, Vasoclean, Mabis, etc. Its products include drugs for digestive, circulatory, and respiratory systems; vitamins, minerals, and nutrients; anti inflammation and analgesics; peripheral ne… Read more
ChoA Pharmaceutical Co.Ltd (034940) - Total Assets
Latest total assets as of September 2025: ₩69.45 Billion KRW
Based on the latest financial reports, ChoA Pharmaceutical Co.Ltd (034940) holds total assets worth ₩69.45 Billion KRW as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
ChoA Pharmaceutical Co.Ltd - Total Assets Trend (2001–2024)
This chart illustrates how ChoA Pharmaceutical Co.Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
ChoA Pharmaceutical Co.Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
ChoA Pharmaceutical Co.Ltd's total assets of ₩69.45 Billion consist of 55.7% current assets and 44.3% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩2.10 Billion | 0.0% |
| Accounts Receivable | ₩15.06 Billion | 21.1% |
| Inventory | ₩12.45 Billion | 17.5% |
| Property, Plant & Equipment | ₩19.71 Billion | 27.6% |
| Intangible Assets | ₩769.00 Million | 1.1% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2001–2024)
This chart illustrates how ChoA Pharmaceutical Co.Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: ChoA Pharmaceutical Co.Ltd's current assets represent 55.7% of total assets in 2024, an increase from 0.0% in 2001.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2024, down from 3.0% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2001.
- Asset Diversification: The largest asset category is property, plant & equipment at 27.6% of total assets.
ChoA Pharmaceutical Co.Ltd Competitors by Total Assets
Key competitors of ChoA Pharmaceutical Co.Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
ChoA Pharmaceutical Co.Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - ChoA Pharmaceutical Co.Ltd generates 0.88x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - ChoA Pharmaceutical Co.Ltd is currently not profitable relative to its asset base.
ChoA Pharmaceutical Co.Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.96 | 1.29 | 2.47 |
| Quick Ratio | 0.61 | 0.90 | 1.81 |
| Cash Ratio | 0.00 | 0.09 | 0.00 |
| Working Capital | ₩-1.45 Billion | ₩ 9.21 Billion | ₩ 28.17 Billion |
ChoA Pharmaceutical Co.Ltd - Advanced Valuation Insights
This section examines the relationship between ChoA Pharmaceutical Co.Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.93 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -3.9% |
| Total Assets | ₩71.32 Billion |
| Market Capitalization | $15.22 Million USD |
Valuation Analysis
Below Book Valuation: The market values ChoA Pharmaceutical Co.Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: ChoA Pharmaceutical Co.Ltd's assets decreased by 3.9% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for ChoA Pharmaceutical Co.Ltd (2001–2024)
The table below shows the annual total assets of ChoA Pharmaceutical Co.Ltd from 2001 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩71.32 Billion | -3.91% |
| 2023-12-31 | ₩74.22 Billion | -13.33% |
| 2022-12-31 | ₩85.64 Billion | +6.37% |
| 2021-12-31 | ₩80.51 Billion | -2.26% |
| 2020-12-31 | ₩82.38 Billion | -5.03% |
| 2019-12-31 | ₩86.74 Billion | +3.21% |
| 2018-12-31 | ₩84.04 Billion | +0.63% |
| 2017-12-31 | ₩83.52 Billion | +11.21% |
| 2016-12-31 | ₩75.10 Billion | +1.01% |
| 2015-12-31 | ₩74.35 Billion | +0.41% |
| 2014-12-31 | ₩74.05 Billion | +4.56% |
| 2013-12-31 | ₩70.82 Billion | +31.86% |
| 2005-12-31 | ₩53.70 Billion | +42.36% |
| 2004-12-31 | ₩37.72 Billion | -23.63% |
| 2003-12-31 | ₩49.39 Billion | -18.49% |
| 2002-12-31 | ₩60.60 Billion | -17.59% |
| 2001-12-31 | ₩73.54 Billion | -- |